封面
市場調查報告書
商品編碼
1758068

全球心臟修復系統市場

Cardiac Restoration Systems

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 270 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球心臟修復系統市場規模將達到 7.599 億美元

全球心臟修復系統市場規模預計在2024年為6.007億美元,到2030年將達到7.599億美元,在2024-2030年的分析期間內,複合年成長率為4.0%。二尖瓣修復系統是本報告分析的細分市場之一,預計其複合年成長率為3.2%,到分析期結束時將達到4.586億美元。左心室修復系統細分市場在分析期間的複合年成長率預計為5.3%。

美國市場規模估計為 1.637 億美元,中國市場預計複合年成長率為 7.2%

美國心臟修復系統市場規模預計2024年達到1.637億美元。作為世界第二大經濟體,中國市場規模預計到2030年將達到1.531億美元,在2024-2030年的分析期間內,複合年成長率為7.2%。其他值得關注的區域市場包括日本和加拿大,預計在分析期間內,複合年成長率分別為1.7%和3.1%。在歐洲,德國的複合年成長率預計為2.3%。

全球心臟修復系統市場-主要趨勢與促進因素摘要

為什麼心臟修復系統會成為晚期心臟衰竭治療的基石?

心臟修復系統作為一種創新的延長生命解決方案,已獲得廣泛關注,適用於心臟衰竭和相關結構性心臟疾病的患者。這些系統旨在重塑、支撐和強化衰竭的心臟,尤其是左心室,使其恢復正常形狀、改善功能並減輕鬱血性的相關症狀。心血管疾病仍然是全球頭號死因,數百萬人患有慢性心臟衰竭衰竭,迫切需要藥物治療和侵入性移植手術的替代方案。心臟修復在藥物治療和更積極的治療方法(例如輔助人工心臟(VAD) 和心臟移植)之間架起了一座橋樑,這對於不適合接受此類治療的患者尤其有價值。心外膜植入、心室重塑裝置和可注射生物支架等系統可以在不顯著損害心臟自然解剖結構的情況下恢復心臟的機械效率。隨著心臟病發作後存活率的提高,越來越多的患者將承受心臟損傷的長期影響,這增加了對修復方法的需求。此外,新興國家早期診斷的改進、對心臟病認知的提高以及心臟護理的改善,正在擴大可從這些治療方法中受益的患者群體。心臟修復系統現在被認為是一種可行的長期解決方案,它不僅可以改善心摶出量,還可以提高患者的生活品質和功能獨立性,最終降低醫療保健利用率和住院費用。

科技進步如何提高心臟修復設備的性能和適應性?

技術創新在擴展心臟修復系統的功能和精確度方面發揮了變革性作用,使其更安全、更有效,並能適應更廣泛的患者解剖結構和疾病進展。材料科學的發展促進了生物相容性和軟性植入材料的開發,這些材料可以模擬心臟組織動態,降低併發症風險並促進與心肌的整合。小型化以及經導管系統和影像引導導航等輸送工具的引入,使得這些設備能夠以微創方式部署,顯著減少手術創傷和恢復時間。一些最新系統使用 3D 列印和患者特定建模,根據患者獨特的心室解剖結構量身定做植入,從而改善治療效果。此外,已經開發出生物可吸收支架和可注射水凝膠,它們可以促進組織再生,同時逐漸分解,無需移除即可留下修復的心臟環境。與即時成像和術中監測技術的結合,可確保設備的精確放置和最佳化功能。此外,整合到修復系統中的智慧材料和生物感測器能夠提供設備性能、壓力梯度和心臟功能的早期回饋,開啟數據驅動的個人化治療時代。這些創新不僅增強了心臟修復系統的治療潛力,也使其適用範圍擴大到更廣泛的心臟衰竭心臟衰竭,包括早期結構性惡化和合併症患者。隨著技術的不斷發展,心臟修復程序正成為現代心臟衰竭管理的標準組成部分。

哪些醫療保健趨勢和臨床實踐正在影響心臟修復系統的需求?

醫療保健服務、臨床指南和患者期望的變化正在深刻影響全球循環系統網路中心臟修復系統的實施。隨著個人化和精準醫療日益受到重視,臨床醫生擴大尋求治療方法解決心臟衰竭潛在機械原因而非僅僅控制症狀的治療方法。心臟修復系統透過針對心室擴張、室壁變薄和收縮力減弱來滿足這一需求,這些都是收縮性心臟衰竭患者心臟心臟衰竭下降的主要促進因素。由循環系統、外科醫生和電生理學家組成的多學科心臟護理團隊的興起也促進了對這些系統進行更廣泛的評估並將其納入標準治療方案。此外,隨著心臟衰竭逐漸成為一種慢性、可控制的疾病,而非立即被診斷為終末期疾病,心臟修復等長期解決方案對於維持患者獨立生活、減少對反覆住院和複雜器械治療的依賴至關重要。保險報銷框架正在不斷發展,以認知到此類系統的成本節約潛力,尤其是在減少再入院以及延緩或避免心臟移植方面。在教育水平的提高、同儕倡導以及將患者與新的治療方案聯繫起來的數位健康平台的推動下,患者對新療法的認知和接受意願也在不斷提高。支持心臟修復設備安全性和有效性的臨床試驗數據越來越可靠,這鼓勵醫生在治療過程中儘早採用這些方法。隨著醫療保健模式轉向更積極主動、以結果為導向的模式,對諸如提供結構矯正和功能恢復的心臟修復系統等治療性介入的需求將持續成長。

是什麼推動了全球心臟修復系統市場的成長?

心臟修復系統市場的成長受到多種因素的共同推動,包括心臟衰竭盛行率的上升、技術進步、良好的臨床療效以及對價值導向醫療的策略性推動。在全球範圍內,人口老化和心肌梗塞後存活率的上升導致患有慢性心臟功能障礙的患者數量不斷增加。不斷成長的患者群體推動了對中階干預措施的需求,這些措施能夠切實改善心臟功能,且無需承擔全外科置換術或機械循環支持的風險和局限性。從技術角度來看,影像處理、材料科學和設備小型化的創新使心臟修復系統更易於取得和部署,使其在學術和社區醫療保健環境中得到更廣泛的應用。良好的臨床試驗數據和真實世界證據表明射血分數、運動能力和症狀緩解均有所改善,進一步檢驗了這些設備的市場潛力。此外,監管途徑也日趨簡化,一些設備已獲得 CE 標誌核准或 FDA 等機構的快速通道認證,從而加快了其市場准入和廣泛應用。從經濟角度來看,醫療保健系統越來越傾向於減少醫院再入院率、積極管理慢性病並降低總護理成本。醫療設備公司、學術機構和醫院網路之間的策略合作也正在刺激獎勵和市場滲透。這些因素共同構成了持續成長的堅實基礎,使心臟修復系統成為不斷發展的心臟衰竭治療領域的關鍵創新。

部分

產品(二尖瓣修復系統、左心室修復系統);最終用途(醫院最終用途、門診手術中心最終用途、其他最終用途)

受訪公司範例

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Cardiac Dimensions, Inc.
  • Cardiovascular Systems, Inc.
  • Corindus Vascular Robotics
  • Edwards Lifesciences
  • Endotronix, Inc.
  • Fresenius Medical Care
  • LivaNova PLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Penumbra, Inc.
  • Shockwave Medical, Inc.
  • Siemens Healthineers
  • Spectranetics Corporation
  • Terumo Corporation
  • Zoll Medical Corporation

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 並未遵循查詢 LLM 或特定產業SLM 的典型規範,而是建立了一個來自全球領域專家的精選內容庫,其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況(成品和原始OEM)預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手,包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP36474

Global Cardiac Restoration Systems Market to Reach US$759.9 Million by 2030

The global market for Cardiac Restoration Systems estimated at US$600.7 Million in the year 2024, is expected to reach US$759.9 Million by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Mitral Valve Restoration Systems, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$458.6 Million by the end of the analysis period. Growth in the Left Ventricular Restoration Systems segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$163.7 Million While China is Forecast to Grow at 7.2% CAGR

The Cardiac Restoration Systems market in the U.S. is estimated at US$163.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$153.1 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Cardiac Restoration Systems Market - Key Trends & Drivers Summarized

Why Are Cardiac Restoration Systems Emerging as a Cornerstone in Advanced Heart Failure Treatment?

Cardiac restoration systems are gaining significant traction as innovative, life-extending solutions for patients suffering from heart failure and related structural heart conditions. These systems are designed to reshape, support, or reinforce the failing heart-particularly the left ventricle-to restore normal geometry, improve function, and reduce symptoms associated with congestive heart failure. As cardiovascular disease remains the leading cause of death globally, with millions affected by chronic heart failure, there is an urgent demand for therapeutic alternatives beyond pharmacological treatment and invasive transplant procedures. Cardiac restoration offers a bridge between medical management and more aggressive interventions like ventricular assist devices (VADs) or heart transplantation, making it particularly valuable for patients who are not suitable candidates for such procedures. Systems such as epicardial implants, ventricular remodeling devices, and injectable bio-scaffolds work to restore the mechanical efficiency of the heart without significantly compromising its natural anatomy. As survival rates post-heart attack improve, more patients are living with the long-term consequences of cardiac damage, driving demand for restorative approaches. Furthermore, improvements in early diagnosis, increased awareness of heart disease, and better access to cardiac care in emerging economies are broadening the patient pool eligible for these interventions. Cardiac restoration systems are now viewed as a viable long-term solution that not only improves cardiac output but also enhances patients' quality of life and functional independence, ultimately reducing healthcare utilization and hospitalization costs.

How Are Technological Innovations Enhancing the Performance and Adaptability of Cardiac Restoration Devices?

Technological innovation is playing a transformative role in expanding the capabilities and precision of cardiac restoration systems, making them safer, more effective, and increasingly adaptable to a wider range of patient anatomies and disease progressions. Advances in material science have led to the development of biocompatible and flexible implant materials that mimic cardiac tissue mechanics, reducing the risk of complications and enhancing integration with the myocardium. Miniaturization and the incorporation of delivery tools like transcatheter systems and image-guided navigation have enabled less invasive deployment of these devices, significantly reducing surgical trauma and recovery times. Some of the latest systems use 3D printing and patient-specific modeling to customize implants based on a patient’s unique ventricular structure, improving therapeutic outcomes. Furthermore, bioresorbable scaffolds and injectable hydrogels are being developed to promote tissue regeneration while gradually degrading, leaving behind a restored cardiac environment without the need for removal. Integration with real-time imaging and intraoperative monitoring technologies ensures precise device placement and function optimization. Additionally, smart materials and biosensors embedded in restoration systems are providing early feedback on device performance, pressure gradients, and cardiac function, ushering in the era of data-driven, personalized therapy. These innovations are not only enhancing the therapeutic potential of cardiac restoration systems but are also expanding their applicability across a broader spectrum of heart failure patients, including those with early-stage structural deterioration or coexisting comorbidities. As technology continues to evolve, cardiac restoration is poised to become a standard component of modern heart failure management.

What Healthcare Trends and Clinical Practices Are Shaping the Demand for Cardiac Restoration Systems?

Shifts in healthcare delivery, clinical guidelines, and patient expectations are significantly influencing the adoption of cardiac restoration systems across global cardiology networks. With the growing emphasis on personalized and precision medicine, clinicians are increasingly looking for treatment modalities that address the root mechanical causes of heart failure rather than simply managing symptoms. Cardiac restoration systems fulfill this demand by targeting ventricular dilation, wall thinning, and impaired contractility, which are key contributors to declining heart function in systolic heart failure. The rise in multidisciplinary heart teams, composed of cardiologists, surgeons, and electrophysiologists, is also facilitating broader evaluation and integration of these systems into standard care protocols. Furthermore, as heart failure becomes a chronic, manageable condition rather than an immediate terminal diagnosis, long-term solutions like cardiac restoration are gaining importance for maintaining patient independence and reducing reliance on repeated hospitalizations or complex device therapy. Reimbursement frameworks are evolving to recognize the cost-saving potential of these systems, particularly in reducing readmissions and delaying or avoiding the need for heart transplants. Patient awareness and willingness to pursue novel therapies have also increased, driven by better education, peer advocacy, and digital health platforms that connect patients to emerging treatment options. Clinical trial data supporting the safety and efficacy of cardiac restoration devices is becoming more robust, encouraging physicians to adopt these approaches earlier in the treatment pathway. As healthcare moves toward more proactive, outcome-oriented models, the demand for therapeutic interventions like cardiac restoration systems that offer structural correction and functional recovery will continue to accelerate.

What’s Driving the Growth of the Global Cardiac Restoration Systems Market?

The growth in the cardiac restoration systems market is driven by several intersecting factors, including the rising prevalence of heart failure, technological advancements, favorable clinical outcomes, and the strategic push toward value-based care. Globally, aging populations and increased survival rates following myocardial infarction are contributing to a larger patient base living with chronic cardiac dysfunction. This expanding population fuels the demand for mid-range interventions that offer tangible improvements in heart function without the risks or limitations of full surgical replacement or mechanical circulatory support. From a technological perspective, innovations in imaging, material science, and device miniaturization are making cardiac restoration systems more accessible and easier to deploy, allowing for broader adoption in both academic and community healthcare settings. Positive clinical trial data and real-world evidence demonstrating improvements in ejection fraction, exercise capacity, and symptom relief are further validating the market potential of these devices. Additionally, regulatory pathways are becoming more streamlined, with several devices gaining CE Mark approval or fast-track designations from agencies like the FDA, facilitating quicker market entry and adoption. On the financial front, healthcare systems are increasingly incentivized to reduce hospital readmissions, manage chronic conditions proactively, and lower the total cost of care-goals that align well with the function and promise of cardiac restoration therapy. Strategic collaborations between medical device companies, academic institutions, and hospital networks are also fueling innovation and market penetration. Altogether, these dynamics are creating a robust foundation for sustained growth, positioning cardiac restoration systems as a critical innovation in the evolving landscape of heart failure treatment.

SCOPE OF STUDY:

The report analyzes the Cardiac Restoration Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Mitral Valve Restoration Systems, Left Ventricular Restoration Systems); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Cardiac Dimensions, Inc.
  • Cardiovascular Systems, Inc.
  • Corindus Vascular Robotics
  • Edwards Lifesciences
  • Endotronix, Inc.
  • Fresenius Medical Care
  • LivaNova PLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Penumbra, Inc.
  • Shockwave Medical, Inc.
  • Siemens Healthineers
  • Spectranetics Corporation
  • Terumo Corporation
  • Zoll Medical Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Cardiac Restoration Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Heart Failure Throws the Spotlight on Cardiac Restoration as a Transformative Therapy Option
    • Limitations of Conventional Treatments Accelerate Demand for Minimally Invasive Cardiac Restoration Systems
    • Expansion of Structural Heart Disease Programs Strengthens the Business Case for Ventricular Restoration Technologies
    • Aging Population and Higher Heart Disease Risk Profiles Sustain Long-Term Need for Cardiac Repair Solutions
    • Breakthroughs in Device-Based Therapies Propel Growth in Left Ventricular Restoration System Adoption
    • Patient Preference for Minimally Invasive Options Drives Adoption of Transcatheter-Based Restoration Platforms
    • Increased Clinical Trials and Real-World Data Enhance Confidence in Efficacy of Cardiac Restoration Devices
    • Hospital Focus on Readmission Reduction and Functional Improvement Supports Integration into Heart Failure Care Pathways
    • Rising Use of Cardiac MRI and Advanced Imaging Fuels Personalized Planning for Restoration Procedures
    • Surge in Advanced Heart Failure Referrals Spurs Market Demand for Bridge-to-Recovery Solutions
    • Integration with Digital Health Tools and Remote Monitoring Strengthens Post-Procedure Outcome Tracking
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiac Restoration Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiac Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Mitral Valve Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Mitral Valve Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Mitral Valve Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Left Ventricular Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Left Ventricular Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Left Ventricular Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Cardiac Restoration Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Cardiac Restoration Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Cardiac Restoration Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Cardiac Restoration Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION